Please find enclosed Financial Results for the quarter and nine- months ended 31st December, 2025
BLACKROSE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Black Rose Industries' board approved standalone and consolidated unaudited results for Q3 FY26 and the nine months ended December 31, 2025. Standalone revenue from operations fell to Rs 7,514.70 lakhs in Q3 FY26 from Rs 8,769.58 lakhs in Q3 FY25, a drop of about 14.3%. Nine-month revenue declined to Rs 21,897.25 lakhs from Rs 25,491.76 lakhs. Net profit for Q3 was Rs 440.78 lakhs (vs Rs 592.12 lakhs) and for 9M stood at Rs 1,308.01 lakhs (vs Rs 2,087.16 lakhs), down roughly 25.6% and 37.3% respectively. EPS for 9M came in at Rs 2.56 versus Rs 4.09 a year ago. The consolidated results also classify the Japan subsidiary B.R. Chemicals Co. Ltd. as a discontinued operation following a board decision in August 2025 to close, sell or transfer it. Statutory auditors M M Nissim & Co LLP issued an unmodified limited review report on both sets of results.
Revenue and profits have shrunk sharply on a year-on-year basis, with margins also under pressure, which is a negative read for shareholders. The move to wind down the loss-making Japan subsidiary is a step toward cleaning up the business but the declining core performance remains the key concern.